Meros Investment Management LP Acquires New Shares in KORU Medical Systems, Inc. $KRMD

Meros Investment Management LP bought a new stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 759,664 shares of the company’s stock, valued at approximately $3,190,589,000. Meros Investment Management LP owned approximately 1.65% of KORU Medical Systems at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of KRMD. BlackRock Inc. bought a new position in KORU Medical Systems during the second quarter valued at approximately $11,039,000. Simcoe Capital LLC bought a new stake in KORU Medical Systems in the fourth quarter worth approximately $3,921,000. Geode Capital Management LLC increased its stake in shares of KORU Medical Systems by 101.3% during the 2nd quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after purchasing an additional 501,875 shares during the last quarter. First Light Asset Management LLC increased its stake in shares of KORU Medical Systems by 5.1% during the 2nd quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock worth $16,760,000 after purchasing an additional 226,700 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of KORU Medical Systems by 189.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after purchasing an additional 158,914 shares in the last quarter. 58.60% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at KORU Medical Systems

In other KORU Medical Systems news, insider Adam R. Kalbermatten bought 12,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The stock was purchased at an average price of $3.94 per share, for a total transaction of $49,250.00. Following the purchase, the insider directly owned 312,500 shares in the company, valued at $1,231,250. This trade represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 18.50% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Weiss Ratings cut shares of KORU Medical Systems from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 19th. Wall Street Zen downgraded shares of KORU Medical Systems from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Craig Hallum restated a “buy” rating and set a $6.00 target price on shares of KORU Medical Systems in a report on Thursday, August 6th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, KORU Medical Systems currently has an average rating of “Moderate Buy” and a consensus price target of $7.00.

KORU Medical Systems Price Performance

Shares of KRMD opened at $3.21 on Wednesday. The company has a market capitalization of $147.44 million, a PE ratio of -80.25 and a beta of 0.45. KORU Medical Systems, Inc. has a one year low of $3.14 and a one year high of $6.61. The company’s fifty day moving average price is $3.94 and its 200 day moving average price is $4.17.

KORU Medical Systems (NASDAQ:KRMD) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.03. The company had revenue of $12.05 million during the quarter, compared to analysts’ expectations of $11.62 million. KORU Medical Systems had a negative net margin of 4.03% and a negative return on equity of 10.63%. Analysts anticipate that KORU Medical Systems, Inc. will post -0.03 earnings per share for the current year.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.